|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
37.450 -0.800 (-2.092%) | 2023/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Turnover | 3,710,850 | 3.245% | 7,085,471 | 5,213,538 | 3,192,279 | 2,803,309 | |
| Cost of Sales | (2,244,568) | 3.157% | (4,300,027) | (2,965,420) | (1,688,946) | (1,511,409) | |
| Gross Profit | 1,466,282 | 3.381% | 2,785,444 | 2,248,118 | 1,503,333 | 1,291,900 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (29,777) | 4.808% | (24,575) | (24,426) | 10,075 | (21,186) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (3,567) | -- | |
| Share of Results of Asso. & JCEs | 63,724 | 79.222% | 39,763 | 14,348 | (3,508) | (9,768) | |
| Profit / (Loss) before Taxation | 1,599,145 | 8.060% | 2,594,912 | 3,689,502 | 2,220,262 | 1,088,772 | |
| Taxation | (191,055) | 17.761% | (313,652) | (292,864) | (189,707) | (113,839) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (19,753) | -84.276% | (265,174) | (517,539) | (279,227) | (133,686) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,388,337 | 16.471% | 2,016,086 | 2,879,099 | 1,751,328 | 841,247 | |
| Net Finance Costs / (Income) | (70,049) | -15.177% | (145,249) | (234,139) | (63,317) | 15,409 | |
| Depreciation & Amortisation | 162,099 | 32.030% | 284,844 | 196,762 | 150,256 | 104,202 | |
| Directors' Emoluments | -- | -- | -- | 3,487 | 3,395 | 2,801 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 161.000 | -- | 233.000 | 332.000 | 220.000 | 113.000 |
| DPS (cts) | 0.000 | -- | 55.000 | 50.000 | 30.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | 23.605% | 15.060% | 13.636% | -- |
| Cash flow per share ($) | -- | -- | -- | 1.343 | 1.125 | 0.725 |
| NBV per share ($) | 23.657 | -- | 22.499 | 20.844 | 18.514 | -- |
| Remarks: | Real time quote last updated: 04/10/2023 17:04 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,388,337 |
| %Change | 16.471% |
| EPS / (LPS) | RMB 1.610 |
| NBV Per Share (¥) | RMB 23.657 |